Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark Study

Area of Science:

• Pharmaceutical Sciences
• Drug Development
• Formulation Science

Background:

• Drug-excipient compatibility studies (DECS) are crucial for stable formulation development.
• Current DECS protocols are lengthy, laborious, and lack standardized guidelines.
• Pharmaceutical industries require efficient methods for excipient screening.

Purpose of the Study:

• To introduce and validate a novel vial-in-vial approach for DECS.
• To compare the efficacy of the novel approach against conventional methods.
• To accelerate the screening of suitable excipients in pre-formulation.

Main Methods:

• A novel vial-in-vial approach was developed and compared with conventional methods.
• Six model drugs with multiple formulations were tested.
• Samples underwent accelerated stability testing (40°C/75% RH) for 3-6 months.
• High-Performance Liquid Chromatography (HPLC) was used for degradation analysis.

Main Results:

• The novel vial-in-vial approach showed significantly more discriminating degradation results compared to conventional methods.
• The proposed method effectively identified drug-excipient incompatibilities.
• Conventional methods, including various exposure conditions, were less sensitive in detecting degradation.

Conclusions:

• The novel vial-in-vial approach offers a more efficient and rapid method for DECS.
• This methodology is expected to significantly shorten the drug development cycle.
• Implementing this approach may prevent unexpected stability issues in later stages of development.